|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
$1,250
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
$26,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-37
|
$373,216
|
$37,322
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Non-Coding RNAs and Cell Transformation
|
1R01CA193300-01
|
$271,516
|
$271,516
|
STEITZ, JOAN
|
YALE UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
$8,125
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
$6,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$810,053
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-02
|
$109,027
|
$109,027
|
OGEMBO, JAVIER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-02
|
$680,259
|
$414,958
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Training In Tumor Virology
|
5T32CA115299-10
|
$342,954
|
$68,591
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-21S1
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-21
|
$4,814,560
|
$48,146
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
5R01CA154228-05
|
$350,675
|
$263,006
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Targeting KSHV malignancies and persistent infection
|
1R01CA197153-01
|
$377,247
|
$377,247
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-05
|
$305,754
|
$152,877
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Studying the role of KSHV-encoded miRNAs
|
5R01CA119917-08
|
$301,913
|
$301,913
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$675,862
|
$202,758
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$163,092
|
$8,155
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Semiparametric inference for case-control studies with complex sampling
|
5R03CA171064-03
|
$67,974
|
$33,987
|
LI, YAN
|
UNIV OF MARYLAND, COLLEGE PARK
|
|
Role of KSHV viral proteins in signaling and pathogenesis
|
5R01CA096500-13
|
$281,108
|
$281,108
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
2R01CA075922-19A1
|
$666,638
|
$666,638
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Research Management and Support
|
RMS ES 2015
|
$348,215,937
|
$22,000
|
Unknown, Unknown
|
National Cancer Institute
|
|
Regulation of KSHV Latency
|
5R01CA117830-10
|
$318,853
|
$318,853
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Regulation of KSHV infection and replication by MAPK pathways
|
5R01CA124332-09
|
$303,864
|
$303,864
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
1R44CA192859-01A1
|
$300,000
|
$300,000
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
|
5R01CA091791-13
|
$284,547
|
$284,547
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Pathogenesis and therapy of KSHV-associated Malignancies
|
ZIA BC 011500
|
$159,014
|
$63,606
|
Polizzotto, Mark
|
CCR (NCI)
|
|
Origin and Lineage of Differentiation of Kaposi's Sarcoma
|
1R21CA192744-01
|
$162,916
|
$162,916
|
SCHNEIDER, JOHANN
|
STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S1
|
$60,000
|
$4,200
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S2
|
$93,744
|
$6,562
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
5P30CA069533-18
|
$1,540,000
|
$107,800
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Molecular mechanisms of transcriptional regulation in the Notch pathway
|
5R01CA178974-03
|
$321,023
|
$105,938
|
KOVALL, RHETT
|
UNIVERSITY OF CINCINNATI
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$455,874
|
$4,559
|
Raffeld, Mark
|
CCR (NCI)
|
|
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis
|
2R01CA082057-15
|
$391,282
|
$391,282
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Modeling KSHV latency in vivo
|
5R01CA103646-09
|
$328,499
|
$328,499
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,389,288
|
$219,464
|
Gulley, James
|
CCR (NCI)
|
|
Mechanism of KSHV-induced angiogenesis
|
2R01CA132637-07A1
|
$391,578
|
$391,578
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Manipulation of kinase signaling by the human oncovirus KSHV
|
5F31CA183250-02
|
$35,875
|
$17,938
|
AVEY, DENIS
|
FLORIDA STATE UNIVERSITY
|
|
LANA and Cellular Gene Expression
|
5R01CA088763-14
|
$230,935
|
$230,935
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
KSHV RTA: more than viral replication
|
5R01CA115284-10
|
$295,985
|
$295,985
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
KSHV Persistence and Pathogenesis
|
5P01CA180779-03
|
$1,472,214
|
$736,107
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
KSHV microRNAs in cellular transformation and tumorigenesis
|
5R01CA177377-03
|
$201,171
|
$201,171
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
KSHV interactions with host inflammasome components
|
5R01CA180758-02
|
$320,588
|
$320,588
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
KSHV Genome Replication during Primary Infection
|
5R01CA174459-03
|
$295,957
|
$198,291
|
VERMA, SUBHASH
|
UNIVERSITY OF NEVADA RENO
|
|
KSHV genome modification in KS tissue
|
5R01CA177423-03
|
$200,000
|
$200,000
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
KSHV alteration of cellular metabolism
|
1R01CA189986-01A1
|
$345,175
|
$345,175
|
LAGUNOFF, MICHAEL
|
UNIVERSITY OF WASHINGTON
|
|
KS-Detect: A solar-powered and smartphone integrated instrument for point-of-care
|
1R43CA193096-01
|
$224,835
|
$224,835
|
JIANG, LI
|
A'AS, INC.
|
|
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs
|
5R01CA180813-02
|
$320,588
|
$320,588
|
GOTTWEIN, EVA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
JHU ICMIC Program
|
5P50CA103175-10
|
$1,485,716
|
$178,286
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis
|
2R01CA136387-06
|
$457,223
|
$457,223
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
Total relevant funding to Kaposi Sarcoma for this search: $25,271,279
|